|
Status |
Public on Jun 23, 2021 |
Title |
Adip.ChIPseq_GR.A4.Dex.2 |
Sample type |
SRA |
|
|
Source name |
Adipocyte
|
Organism |
Homo sapiens |
Characteristics |
cell type: hASC-derived adipocytes chip antibody: GR
|
Treatment protocol |
adipocytes were treated with 1uM dexamethasone for 24h beginning at day 24 for RNA-seq, 6h beginning at day 20 for ChIP-seq, hepatocytes were treated with 1uM dexamethasone for 24h beginning at day 20 for RNA-seq, 6h beginning at day 20 for ChIP-seq, ATAC-seq and ChIA-PET
|
Extracted molecule |
genomic DNA |
Extraction protocol |
none provided by the submitter
|
|
|
Library strategy |
ChIP-Seq |
Library source |
genomic |
Library selection |
ChIP |
Instrument model |
HiSeq X Ten |
|
|
Description |
MergedPeakFile.Adipocyte.txt
|
Data processing |
none provided by the submitter Genome_build: hg38
|
|
|
Submission date |
Dec 14, 2020 |
Last update date |
Jun 23, 2021 |
Contact name |
Chunjie Jiang |
E-mail(s) |
chunjie.jiang917@outlook.com
|
Phone |
2153164211
|
Organization name |
University of Pennsylvania
|
Department |
Institute for Diabetes, Obesity, and Metabolism
|
Lab |
Mitchell A. Lazar
|
Street address |
3400 Civic Center Boulevard
|
City |
Philadelphia |
State/province |
PA |
ZIP/Postal code |
19104 |
Country |
USA |
|
|
Platform ID |
GPL20795 |
Series (1) |
GSE163061 |
Individual-specific functional epigenomics reveals genetic determinants of adverse metabolic effects of glucocorticoids |
|
Relations |
BioSample |
SAMN17077985 |
SRA |
SRX9683845 |